Selected research
Industry Growth & Trends
Global Pet Biological Products Industry Growth and Trends Forecast to 2032
Market perspective
The global Pet Biological Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pet Biological Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pet Biological Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pet Biological Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pet Biological Products include Zoetis, Merck, Wuhan chopperlvya, Virbac, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun and Elanco, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pet Biological Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pet Biological Products market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pet Biological Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pet Biological Products.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Pet Biological Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pet Biological Products Market by Company
Zoetis
Merck
Wuhan chopperlvya
Virbac
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Elanco
Dechra Veterinary Products
Ceva
CAHIC
Boehringer Ingelheim
Pet Biological Products Segment by Type
Drug
Vaccine
Pet Biological Products Segment by Application
Reptile
Cat
Dog
Other
Pet Biological Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Biological Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Biological Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Biological Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Biological Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pet Biological Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drug
- Vaccine
Applications
- Reptile
- Cat
- Dog
- Other
Companies covered
- Zoetis
- Merck
- Wuhan chopperlvya
- Virbac
- Vetoquinol
- Ouro Fino Saude
- Norbrook
- Jindun
- Elanco
- Dechra Veterinary Products
- Ceva
- CAHIC
- Boehringer Ingelheim
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pet Biological Products Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Pet Biological Products Sales Estimates and Forecasts (2021-2032)
- 1.3 Pet Biological Products Market by Type
- 1.3.1 Drug
- 1.3.2 Vaccine
- 1.4 Global Pet Biological Products Market Size by Type
- 1.4.1 Global Pet Biological Products Market Size Overview by Type (2021-2032)
- 1.4.2 Global Pet Biological Products Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Pet Biological Products Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Pet Biological Products Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Pet Biological Products Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Pet Biological Products Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Pet Biological Products Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Pet Biological Products Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Pet Biological Products Industry Trends
- 2.2 Pet Biological Products Industry Drivers
- 2.3 Pet Biological Products Industry Opportunities and Challenges
- 2.4 Pet Biological Products Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Pet Biological Products Revenue (2021-2026)
- 3.2 Global Top Players by Pet Biological Products Sales (2021-2026)
- 3.3 Global Top Players by Pet Biological Products Price (2021-2026)
- 3.4 Global Pet Biological Products Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pet Biological Products Major Company Production Sites & Headquarters
- 3.6 Global Pet Biological Products Company, Product Type & Application
- 3.7 Global Pet Biological Products Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pet Biological Products Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pet Biological Products Players Market Share by Revenue in 2025
- 3.8.3 2025 Pet Biological Products Tier 1, Tier 2, and Tier 3
4 Pet Biological Products Regional Status and Outlook
- 4.1 Global Pet Biological Products Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Pet Biological Products Historic Market Size by Region
- 4.2.1 Global Pet Biological Products Sales in Volume by Region (2021-2026)
- 4.2.2 Global Pet Biological Products Sales in Value by Region (2021-2026)
- 4.2.3 Global Pet Biological Products Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Pet Biological Products Forecasted Market Size by Region
- 4.3.1 Global Pet Biological Products Sales in Volume by Region (2027-2032)
- 4.3.2 Global Pet Biological Products Sales in Value by Region (2027-2032)
- 4.3.3 Global Pet Biological Products Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pet Biological Products by Application
- 5.1 Pet Biological Products Market by Application
- 5.1.1 Reptile
- 5.1.2 Cat
- 5.1.3 Dog
- 5.1.4 Other
- 5.2 Global Pet Biological Products Market Size by Application
- 5.2.1 Global Pet Biological Products Market Size Overview by Application (2021-2032)
- 5.2.2 Global Pet Biological Products Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Pet Biological Products Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Pet Biological Products Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Pet Biological Products Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Pet Biological Products Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Pet Biological Products Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Pet Biological Products Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Zoetis
- 6.1.1 Zoetis Company Information
- 6.1.2 Zoetis Business Overview
- 6.1.3 Zoetis Pet Biological Products Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Zoetis Pet Biological Products Product Portfolio
- 6.1.5 Zoetis Recent Developments
- 6.2 Merck
- 6.2.1 Merck Company Information
- 6.2.2 Merck Business Overview
- 6.2.3 Merck Pet Biological Products Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Merck Pet Biological Products Product Portfolio
- 6.2.5 Merck Recent Developments
- 6.3 Wuhan chopperlvya
- 6.3.1 Wuhan chopperlvya Company Information
- 6.3.2 Wuhan chopperlvya Business Overview
- 6.3.3 Wuhan chopperlvya Pet Biological Products Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Wuhan chopperlvya Pet Biological Products Product Portfolio
- 6.3.5 Wuhan chopperlvya Recent Developments
- 6.4 Virbac
- 6.4.1 Virbac Company Information
- 6.4.2 Virbac Business Overview
- 6.4.3 Virbac Pet Biological Products Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Virbac Pet Biological Products Product Portfolio
- 6.4.5 Virbac Recent Developments
- 6.5 Vetoquinol
- 6.5.1 Vetoquinol Company Information
- 6.5.2 Vetoquinol Business Overview
- 6.5.3 Vetoquinol Pet Biological Products Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Vetoquinol Pet Biological Products Product Portfolio
- 6.5.5 Vetoquinol Recent Developments
- 6.6 Ouro Fino Saude
- 6.6.1 Ouro Fino Saude Company Information
- 6.6.2 Ouro Fino Saude Business Overview
- 6.6.3 Ouro Fino Saude Pet Biological Products Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Ouro Fino Saude Pet Biological Products Product Portfolio
- 6.6.5 Ouro Fino Saude Recent Developments
- 6.7 Norbrook
- 6.7.1 Norbrook Company Information
- 6.7.2 Norbrook Business Overview
- 6.7.3 Norbrook Pet Biological Products Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Norbrook Pet Biological Products Product Portfolio
- 6.7.5 Norbrook Recent Developments
- 6.8 Jindun
- 6.8.1 Jindun Company Information
- 6.8.2 Jindun Business Overview
- 6.8.3 Jindun Pet Biological Products Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Jindun Pet Biological Products Product Portfolio
- 6.8.5 Jindun Recent Developments
- 6.9 Elanco
- 6.9.1 Elanco Company Information
- 6.9.2 Elanco Business Overview
- 6.9.3 Elanco Pet Biological Products Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Elanco Pet Biological Products Product Portfolio
- 6.9.5 Elanco Recent Developments
- 6.10 Dechra Veterinary Products
- 6.10.1 Dechra Veterinary Products Company Information
- 6.10.2 Dechra Veterinary Products Business Overview
- 6.10.3 Dechra Veterinary Products Pet Biological Products Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Dechra Veterinary Products Pet Biological Products Product Portfolio
- 6.10.5 Dechra Veterinary Products Recent Developments
- 6.11 Ceva
- 6.11.1 Ceva Company Information
- 6.11.2 Ceva Business Overview
- 6.11.3 Ceva Pet Biological Products Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Ceva Pet Biological Products Product Portfolio
- 6.11.5 Ceva Recent Developments
- 6.12 CAHIC
- 6.12.1 CAHIC Company Information
- 6.12.2 CAHIC Business Overview
- 6.12.3 CAHIC Pet Biological Products Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 CAHIC Pet Biological Products Product Portfolio
- 6.12.5 CAHIC Recent Developments
- 6.13 Boehringer Ingelheim
- 6.13.1 Boehringer Ingelheim Company Information
- 6.13.2 Boehringer Ingelheim Business Overview
- 6.13.3 Boehringer Ingelheim Pet Biological Products Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Boehringer Ingelheim Pet Biological Products Product Portfolio
- 6.13.5 Boehringer Ingelheim Recent Developments
7 North America by Country
- 7.1 North America Pet Biological Products Sales by Country
- 7.1.1 North America Pet Biological Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Pet Biological Products Sales by Country (2021-2026)
- 7.1.3 North America Pet Biological Products Sales Forecast by Country (2027-2032)
- 7.2 North America Pet Biological Products Market Size by Country
- 7.2.1 North America Pet Biological Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Pet Biological Products Market Size by Country (2021-2026)
- 7.2.3 North America Pet Biological Products Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Pet Biological Products Sales by Country
- 8.1.1 Europe Pet Biological Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Pet Biological Products Sales by Country (2021-2026)
- 8.1.3 Europe Pet Biological Products Sales Forecast by Country (2027-2032)
- 8.2 Europe Pet Biological Products Market Size by Country
- 8.2.1 Europe Pet Biological Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Pet Biological Products Market Size by Country (2021-2026)
- 8.2.3 Europe Pet Biological Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Pet Biological Products Sales by Country
- 9.1.1 Asia-Pacific Pet Biological Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Pet Biological Products Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Pet Biological Products Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Pet Biological Products Market Size by Country
- 9.2.1 Asia-Pacific Pet Biological Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Pet Biological Products Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Pet Biological Products Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Pet Biological Products Sales by Country
- 10.1.1 South America Pet Biological Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Pet Biological Products Sales by Country (2021-2026)
- 10.1.3 South America Pet Biological Products Sales Forecast by Country (2027-2032)
- 10.2 South America Pet Biological Products Market Size by Country
- 10.2.1 South America Pet Biological Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Pet Biological Products Market Size by Country (2021-2026)
- 10.2.3 South America Pet Biological Products Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Pet Biological Products Sales by Country
- 11.1.1 Middle East and Africa Pet Biological Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Pet Biological Products Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Pet Biological Products Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Pet Biological Products Market Size by Country
- 11.2.1 Middle East and Africa Pet Biological Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Pet Biological Products Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Pet Biological Products Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Pet Biological Products Value Chain Analysis
- 12.1.1 Pet Biological Products Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Pet Biological Products Production Mode & Process
- 12.2 Pet Biological Products Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Pet Biological Products Distributors
- 12.2.3 Pet Biological Products Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst